Skip to Content
Merck
  • Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor.

Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor.

Journal of medicinal chemistry (2011-12-16)
Pradeep Cheruku, Alberto Plaza, Gianluigi Lauro, Jessica Keffer, John R Lloyd, Giuseppe Bifulco, Carole A Bewley
ABSTRACT

The discovery, structure elucidation, and solid-phase synthesis of namalide, a marine natural product, are described. Namalide is a cyclic tetrapeptide; its macrocycle is formed by only three amino acids, with an exocyclic ureido phenylalanine moiety at its C-terminus. The absolute configuration of namalide was established, and analogs were generated through Fmoc-based solid phase peptide synthesis. We found that only natural namalide and not its analogs containing l-Lys or l-allo-Ile inhibited carboxypeptidase A at submicromolar concentrations. In parallel, an inverse virtual screening approach aimed at identifying protein targets of namalide selected carboxypeptidase A as the third highest scoring hit. Namalide represents a new anabaenopeptin-type scaffold, and its protease inhibitory activity demonstrates that the 13-membered macrolactam can exhibit similar activity as the more common hexapeptides.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carboxypeptidase A from bovine pancreas, (Type II-PMSF treated), ≥50 units/mg protein, ready-to-use solution
Sigma-Aldrich
Carboxypeptidase A−Agarose, ammonium sulfate suspension, ≥6 units/mL packed gel, 25 °C, enzyme from bovine pancreas